맞춤형 수술 키트 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 수술별, 최종 용도별, 지역별 및 부문별 전망(2026-2033년)

Custom Procedure Kits Market Summary

The global custom procedure kits market size was valued at USD 9.1 billion in 2025 and is projected to grow from USD 10.1 billion in 2026 to USD 20.9 billion by 2033, at a CAGR of 11.0% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 45.4% in 2025. The market growth is supported by increasing use of customized procedure kits across hospitals, ambulatory surgical centers, and specialty facilities to standardize supplies, simplify procedure preparation, and streamline perioperative workflows, as demonstrated by Owens & Minor's launch of Halyard Kitting in May 2026 to expand medical procedure tray manufacturing capabilities for acute and non-acute care settings.

Custom procedure kits consolidate procedure-specific medical supplies and consumables into a single sterile package, helping surgical teams simplify preparation, standardize setup, and manage components more efficiently. Demand is further supported by rising procedure volumes and the need to streamline operating room workflows while maintaining consistent infection-control practices. Customized kits allow healthcare facilities to select components according to specific procedural requirements, reducing the need to gather individually packaged items. In January 2026, Molnlycke reported producing 100 million ProcedurePak trays and stated that customized trays can reduce surgical preparation time by up to 40%, highlighting their potential to improve operating room efficiency.

Healthcare providers are focused on supply utilization, operating room efficiency, and procedure-specific standardization, supporting demand for custom procedure kits. By consolidating required components, these kits can simplify pre-procedure preparation and promote consistent operating room setup, particularly in high-volume surgical environments. Manufacturers are also expanding their capabilities and portfolios to address the diverse requirements of hospitals and surgical centers. For instance, in April 2025, Lohmann & Rauscher acquired Unisurge International, a UK supplier of Custom Procedure Packs, disposable surgical products, and instruments. L&R stated that the acquisition would expand its access to the UK hospital and operating room products market and form part of its strategic M&A-led growth strategy.

Healthcare providers use custom procedure kits as they consolidate procedure-specific medical supplies and consumables into a pre-assembled format. By combining required components in a single kit, these solutions reduce the time and effort needed to collect individual items before a procedure and maintain consistent operating room setups. Customized configurations also allow hospitals and ambulatory surgical centers to select components according to specific clinical and procedural requirements. This is particularly relevant for facilities that manage diverse, high-volume procedures, where the availability of supplies, preparation time, and workflow consistency directly affect operating efficiency.

Global Custom Procedure Kits Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global custom procedure kits market report based on product, procedure, end use, and region:

• Product Outlook (Revenue, USD Billion, 2021 - 2033)
• Disposable
• Reusable
• Procedure Outlook (Revenue, USD Billion, 2021 - 2033)
• Colorectal
• Thoracic
• Orthopedic
• Ophthalmology
• Neurosurgery
• Cardiac Surgery
• Gynecology
• General Surgery
• Urology
• Others
• End Use Outlook (Revenue, USD Billion, 2021 - 2033)
• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Others
• Regional Outlook (Revenue, USD Billion, 2021-2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Product
  • 1.1.2. Procedure
  • 1.1.3. End Use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Details of primary research
  • 1.4.4. Market Formulation & Validation
  • 1.4.5. Model Details
    • 1.4.5.1. Commodity flow analysis (Model 1)
      • 1.4.5.1.1. Approach 1: Commodity flow approach
    • 1.4.5.2. Volume price analysis (Model 2)
      • 1.4.5.2.1. Approach 2: Volume price analysis
  • 1.4.6. Research Scope and Assumptions
    • 1.4.6.1. List of Secondary Sources
    • 1.4.6.2. List of Primary Sources
    • 1.4.6.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Custom Procedure Kits Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Growing focus on procedure standardization due to rising surgeries
    • 3.2.1.2. Increasing emphasis on operating room efficiency
    • 3.2.1.3. Expansion of ambulatory surgical center procedures
    • 3.2.1.4. Need to reduce procedural preparation time
    • 3.2.1.5. Greater focus on healthcare-associated infection prevention
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. Higher customization increases kit manufacturing complexity
    • 3.2.2.2. Customized kits require extensive inventory management
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Integration of advanced specialty-specific procedural components
    • 3.2.3.2. Expansion into emerging ambulatory surgical markets
    • 3.2.3.3. Development of digitally configured ordering platforms
    • 3.2.3.4. Growing demand for environmentally optimized kit designs
    • 3.2.3.5. Partnerships with hospitals enable tailored kit development
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Maintaining consistent quality across customized configurations
    • 3.2.4.2. Managing numerous component combinations increases complexity
• 3.3. Custom Procedure Kits Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape

Chapter 4. Custom Procedure Kits Market: Product Outlook Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Custom Procedure Kits Market: Product Outlook Movement Analysis, 2025 & 2033 (USD Billion)
• 4.3. Global Custom Procedure Kits Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Billion)
  • 4.3.1. Disposable
    • 4.3.1.1. Disposable market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 4.3.2. Reusable
    • 4.3.2.1. Reusable market revenue estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 5. Custom Procedure Kits Market: Procedure Outlook Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Custom Procedure Kits Market: Procedure Outlook Movement Analysis, 2025 & 2033 (USD Billion)
• 5.3. Global Custom Procedure Kits Market Size & Trend Analysis, by Procedure, 2021 to 2033 (USD Billion)
  • 5.3.1. Colorectal
    • 5.3.1.1. Colorectal market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 5.3.2. Thoracic
    • 5.3.2.1. Thoracic market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 5.3.3. Orthopedic
    • 5.3.3.1. Orthopedic market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 5.3.4. Ophthalmology
    • 5.3.4.1. Ophthalmology market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 5.3.5. Neurosurgery
    • 5.3.5.1. Neurosurgery market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 5.3.6. Cardiac Surgery
    • 5.3.6.1. Cardiac Surgery market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 5.3.7. Gynecology
    • 5.3.7.1. Gynecology market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 5.3.8. General Surgery
    • 5.3.8.1. General Surgery market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 5.3.9. Urology
    • 5.3.9.1. Urology market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 5.3.10. Others
    • 5.3.10.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 6. Custom Procedure Kits Market: End Use Outlook Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Custom Procedure Kits Market: End Use Outlook Movement Analysis, 2025 & 2033 (USD Billion)
• 6.3. Global Custom Procedure Kits Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Billion)
  • 6.3.1. Hospitals
    • 6.3.1.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.3.2. Ambulatory Surgical Centers
    • 6.3.2.1. Ambulatory Surgical Centers market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.3.3. Clinics
    • 6.3.3.1. Clinics market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.3.4. Others
    • 6.3.4.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 7. Custom Procedure Kits Market: Regional Estimates & Trend Analysis by Product, Procedure, and End Use

• 7.1. Regional Dashboard
• 7.2. Market Size and Trend Analysis, 2021 to 2033
  • 7.2.1. North America
    • 7.2.1.1. North America custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 7.2.1.2. U.S.
      • 7.2.1.2.1. Key country dynamics
      • 7.2.1.2.2. Competitive scenario
      • 7.2.1.2.3. Regulatory framework
      • 7.2.1.2.4. Reimbursement scenario
      • 7.2.1.2.5. U.S. custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 7.2.1.3. Canada
      • 7.2.1.3.1. Key country dynamics
      • 7.2.1.3.2. Competitive scenario
      • 7.2.1.3.3. Regulatory framework
      • 7.2.1.3.4. Reimbursement scenario
      • 7.2.1.3.5. Canada custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 7.2.1.4. Mexico
      • 7.2.1.4.1. Key country dynamics
      • 7.2.1.4.2. Competitive scenario
      • 7.2.1.4.3. Regulatory framework
      • 7.2.1.4.4. Reimbursement scenario
      • 7.2.1.4.5. Mexico custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.2.2. Europe
    • 7.2.2.1. Europe custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 7.2.2.2. UK
      • 7.2.2.2.1. Key country dynamics
      • 7.2.2.2.2. Competitive scenario
      • 7.2.2.2.3. Regulatory framework
      • 7.2.2.2.4. Reimbursement scenario
      • 7.2.2.2.5. UK custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 7.2.2.3. Germany
      • 7.2.2.3.1. Key country dynamics
      • 7.2.2.3.2. Competitive scenario
      • 7.2.2.3.3. Regulatory framework
      • 7.2.2.3.4. Reimbursement scenario
      • 7.2.2.3.5. Germany custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 7.2.2.4. France
      • 7.2.2.4.1. Key country dynamics
      • 7.2.2.4.2. Competitive scenario
      • 7.2.2.4.3. Regulatory framework
      • 7.2.2.4.4. Reimbursement scenario
      • 7.2.2.4.5. France custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 7.2.2.5. Italy
      • 7.2.2.5.1. Key country dynamics
      • 7.2.2.5.2. Competitive scenario
      • 7.2.2.5.3. Regulatory framework
      • 7.2.2.5.4. Reimbursement scenario
      • 7.2.2.5.5. Italy custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 7.2.2.6. Spain
      • 7.2.2.6.1. Key country dynamics
      • 7.2.2.6.2. Competitive scenario
      • 7.2.2.6.3. Regulatory framework
      • 7.2.2.6.4. Reimbursement scenario
      • 7.2.2.6.5. Spain custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 7.2.2.7. Denmark
      • 7.2.2.7.1. Key country dynamics
      • 7.2.2.7.2. Competitive scenario
      • 7.2.2.7.3. Regulatory framework
      • 7.2.2.7.4. Reimbursement scenario
      • 7.2.2.7.5. Denmark custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 7.2.2.8. Sweden
      • 7.2.2.8.1. Key country dynamics
      • 7.2.2.8.2. Competitive scenario
      • 7.2.2.8.3. Regulatory framework
      • 7.2.2.8.4. Reimbursement scenario
      • 7.2.2.8.5. Sweden custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 7.2.2.9. Norway
      • 7.2.2.9.1. Key country dynamics
      • 7.2.2.9.2. Competitive scenario
      • 7.2.2.9.3. Regulatory framework
      • 7.2.2.9.4. Reimbursement scenario
      • 7.2.2.9.5. Norway custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.2.3. Asia Pacific
    • 7.2.3.1. Asia Pacific custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 7.2.3.2. Japan
      • 7.2.3.2.1. Key country dynamics
      • 7.2.3.2.2. Competitive scenario
      • 7.2.3.2.3. Regulatory framework
      • 7.2.3.2.4. Reimbursement scenario
      • 7.2.3.2.5. Japan custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 7.2.3.3. China
      • 7.2.3.3.1. Key country dynamics
      • 7.2.3.3.2. Competitive scenario
      • 7.2.3.3.3. Regulatory framework
      • 7.2.3.3.4. Reimbursement scenario
      • 7.2.3.3.5. China custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 7.2.3.4. India
      • 7.2.3.4.1. Key country dynamics
      • 7.2.3.4.2. Competitive scenario
      • 7.2.3.4.3. Regulatory framework
      • 7.2.3.4.4. Reimbursement scenario
      • 7.2.3.4.5. India custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 7.2.3.5. Thailand
      • 7.2.3.5.1. Key country dynamics
      • 7.2.3.5.2. Competitive scenario
      • 7.2.3.5.3. Regulatory framework
      • 7.2.3.5.4. Reimbursement scenario
      • 7.2.3.5.5. Thailand custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 7.2.3.6. Australia
      • 7.2.3.6.1. Key country dynamics
      • 7.2.3.6.2. Competitive scenario
      • 7.2.3.6.3. Regulatory framework
      • 7.2.3.6.4. Reimbursement scenario
      • 7.2.3.6.5. Australia custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 7.2.3.7. South Korea
      • 7.2.3.7.1. Key country dynamics
      • 7.2.3.7.2. Competitive scenario
      • 7.2.3.7.3. Regulatory framework
      • 7.2.3.7.4. Reimbursement scenario
      • 7.2.3.7.5. South Korea custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.2.4. Latin America
    • 7.2.4.1. Latin America custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 7.2.4.2. Brazil
      • 7.2.4.2.1. Key country dynamics
      • 7.2.4.2.2. Competitive scenario
      • 7.2.4.2.3. Regulatory framework
      • 7.2.4.2.4. Reimbursement scenario
      • 7.2.4.2.5. Brazil custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 7.2.4.3. Argentina
      • 7.2.4.3.1. Key country dynamics
      • 7.2.4.3.2. Competitive scenario
      • 7.2.4.3.3. Regulatory framework
      • 7.2.4.3.4. Reimbursement scenario
      • 7.2.4.3.5. Argentina custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.2.5. Middle East and Africa
    • 7.2.5.1. Middle East and Africa custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 7.2.5.2. South Africa
      • 7.2.5.2.1. Key country dynamics
      • 7.2.5.2.2. Competitive scenario
      • 7.2.5.2.3. Regulatory framework
      • 7.2.5.2.4. Reimbursement scenario
      • 7.2.5.2.5. South Africa custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 7.2.5.3. Saudi Arabia
      • 7.2.5.3.1. Key country dynamics
      • 7.2.5.3.2. Competitive scenario
      • 7.2.5.3.3. Regulatory framework
      • 7.2.5.3.4. Reimbursement scenario
      • 7.2.5.3.5. Saudi Arabia custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 7.2.5.4. UAE
      • 7.2.5.4.1. Key country dynamics
      • 7.2.5.4.2. Competitive scenario
      • 7.2.5.4.3. Regulatory framework
      • 7.2.5.4.4. Reimbursement scenario
      • 7.2.5.4.5. UAE custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)
    • 7.2.5.5. Kuwait
      • 7.2.5.5.1. Key country dynamics
      • 7.2.5.5.2. Competitive scenario
      • 7.2.5.5.3. Regulatory framework
      • 7.2.5.5.4. Reimbursement scenario
      • 7.2.5.5.5. Kuwait custom procedure kits market estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis by Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Market Share Analysis, 2025
• 8.4. Company Heat Map Analysis
• 8.5. Strategy Mapping
  • 8.5.1. Expansion
  • 8.5.2. Mergers & Acquisition
  • 8.5.3. Partnerships & Collaborations
  • 8.5.4. New Technology Launches
  • 8.5.5. Research And Development
  • 8.5.6. Company Profiles
  • 8.5.7. Medline Industries, Inc.
    • 8.5.7.1. Company overview
    • 8.5.7.2. Financial performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. Cardinal Health
    • 8.5.8.1. Company overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Product Benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. Owens & Minor
    • 8.5.9.1. Company overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Product Benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. Molnlycke Health Care AB
    • 8.5.10.1. Company overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Product Benchmarking
    • 8.5.10.4. Strategic initiatives
  • 8.5.11. B. Braun SE
    • 8.5.11.1. Company overview
    • 8.5.11.2. Financial performance
    • 8.5.11.3. Product Benchmarking
    • 8.5.11.4. Strategic initiatives
  • 8.5.12. Merck KGaA
    • 8.5.12.1. Company overview
    • 8.5.12.2. Financial performance
    • 8.5.12.3. Product Benchmarking
    • 8.5.12.4. Strategic initiatives
  • 8.5.13. Merit Medical Systems
    • 8.5.13.1. Company overview
    • 8.5.13.2. Financial performance
    • 8.5.13.3. Product Benchmarking
    • 8.5.13.4. Strategic initiatives
  • 8.5.14. Medtronic
    • 8.5.14.1. Company overview
    • 8.5.14.2. Financial performance
    • 8.5.14.3. Product Benchmarking
    • 8.5.14.4. Strategic initiatives
  • 8.5.15. Teleflex Incorporated
    • 8.5.15.1. Company overview
    • 8.5.15.2. Financial performance
    • 8.5.15.3. Product Benchmarking
    • 8.5.15.4. Strategic initiatives
  • 8.5.16. STERIS
    • 8.5.16.1. Company overview
    • 8.5.16.2. Financial performance
    • 8.5.16.3. Product Benchmarking
    • 8.5.16.4. Strategic initiatives
  • 8.5.17. PAUL HARTMANN AG
    • 8.5.17.1. Company overview
    • 8.5.17.2. Financial performance
    • 8.5.17.3. Product Benchmarking
    • 8.5.17.4. Strategic initiatives
  • 8.5.18. Lohmann & Rauscher GmbH & Co. KG
    • 8.5.18.1. Company overview
    • 8.5.18.2. Financial performance
    • 8.5.18.3. Product Benchmarking
    • 8.5.18.4. Strategic initiatives
  • 8.5.19. Kimal
    • 8.5.19.1. Company overview
    • 8.5.19.2. Financial performance
    • 8.5.19.3. Product Benchmarking
    • 8.5.19.4. Strategic initiatives
  • 8.5.20. Ivor Shaw T/A Pennine Healthcare
    • 8.5.20.1. Company overview
    • 8.5.20.2. Financial performance
    • 8.5.20.3. Product Benchmarking
    • 8.5.20.4. Strategic initiatives
  • 8.5.21. Unisurge International Limited
    • 8.5.21.1. Company overview
    • 8.5.21.2. Financial performance
    • 8.5.21.3. Product Benchmarking
    • 8.5.21.4. Strategic initiatives